{
  "spec_version": "3",
  "endpoint": "segments",
  "stock_code": "2267",
  "company_name": "ヤクルト本社",
  "content_lang": "ja",
  "meta_lang": "en",
  "canonical_url": "https://the-shashi.com/tse/2267/financials/",
  "api_url": "/api/2267/segments.json",
  "updated": "2026-09-04",
  "license": "© 2026 Yutaka Sugiura. All rights reserved.",
  "attribution": "The社史 (the-shashi.com) — https://the-shashi.com/tse/2267/financials/",
  "source": {
    "primary": [
      "有価証券報告書（セグメント情報）"
    ],
    "extraction": "EDINET の XBRL から機械抽出",
    "caveat": "セグメント区分は各期の開示区分をそのまま採録しており、期をまたいだ区分の連続性は保証しない"
  },
  "segment": [
    {
      "FY": "FY05",
      "period": "2006/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "飲料および食品製造販売事業",
      "sales": 229684,
      "profit": 25432,
      "assets": 211835
    },
    {
      "FY": "FY05",
      "period": "2006/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品製造販売事業",
      "sales": 24245,
      "profit": 7528,
      "assets": 28321
    },
    {
      "FY": "FY05",
      "period": "2006/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "その他事業",
      "sales": 13776,
      "profit": 535,
      "assets": 6780
    },
    {
      "FY": "FY06",
      "period": "2007/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "飲料および食品製造販売事業",
      "sales": 233138,
      "profit": 26105,
      "assets": 236315
    },
    {
      "FY": "FY06",
      "period": "2007/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品製造販売事業",
      "sales": 25698,
      "profit": 9414,
      "assets": 32201
    },
    {
      "FY": "FY06",
      "period": "2007/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "その他事業",
      "sales": 14262,
      "profit": 223,
      "assets": 7909
    },
    {
      "FY": "FY07",
      "period": "2008/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "飲料および食品製造販売事業",
      "sales": 271134,
      "profit": 23294,
      "assets": 267051
    },
    {
      "FY": "FY07",
      "period": "2008/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品製造販売事業",
      "sales": 31003,
      "profit": 11159,
      "assets": 37879
    },
    {
      "FY": "FY07",
      "period": "2008/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "その他事業",
      "sales": 15198,
      "profit": 289,
      "assets": 8152
    },
    {
      "FY": "FY08",
      "period": "2009/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "飲料および食品製造販売事業",
      "sales": 244191,
      "profit": 17133,
      "assets": 256294
    },
    {
      "FY": "FY08",
      "period": "2009/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品製造販売事業",
      "sales": 35235,
      "profit": 12110,
      "assets": 37065
    },
    {
      "FY": "FY08",
      "period": "2009/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "その他事業",
      "sales": 14063,
      "profit": 533,
      "assets": 8012
    },
    {
      "FY": "FY09",
      "period": "2010/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 174610,
      "profit": 7411,
      "assets": 155481
    },
    {
      "FY": "FY09",
      "period": "2010/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "米州",
      "sales": 34595,
      "profit": 7662,
      "assets": 53399
    },
    {
      "FY": "FY09",
      "period": "2010/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "アジア・オセアニア",
      "sales": 22475,
      "profit": 4284,
      "assets": 56846
    },
    {
      "FY": "FY09",
      "period": "2010/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヨーロッパ",
      "sales": 9671,
      "profit": 584,
      "assets": 8222
    },
    {
      "FY": "FY09",
      "period": "2010/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品製造販売事業",
      "sales": 35079,
      "profit": 10625,
      "assets": 36804
    },
    {
      "FY": "FY09",
      "period": "2010/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "その他事業",
      "sales": 14246,
      "profit": 3,
      "assets": 7460
    },
    {
      "FY": "FY10",
      "period": "2011/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 179515,
      "profit": 11009,
      "assets": 155692
    },
    {
      "FY": "FY10",
      "period": "2011/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "米州",
      "sales": 37585,
      "profit": 8298,
      "assets": 54844
    },
    {
      "FY": "FY10",
      "period": "2011/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "アジア・オセアニア",
      "sales": 25477,
      "profit": 4101,
      "assets": 59738
    },
    {
      "FY": "FY10",
      "period": "2011/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヨーロッパ",
      "sales": 8608,
      "profit": 570,
      "assets": 7466
    },
    {
      "FY": "FY10",
      "period": "2011/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品製造販売事業",
      "sales": 38878,
      "profit": 10243,
      "assets": 33505
    },
    {
      "FY": "FY10",
      "period": "2011/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "その他事業",
      "sales": 15878,
      "profit": -668,
      "assets": 9179
    },
    {
      "FY": "FY11",
      "period": "2012/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 178010,
      "profit": 9863,
      "assets": 166606
    },
    {
      "FY": "FY11",
      "period": "2012/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "米州",
      "sales": 39039,
      "profit": 8797,
      "assets": 49665
    },
    {
      "FY": "FY11",
      "period": "2012/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "アジア・オセアニア",
      "sales": 31953,
      "profit": 5526,
      "assets": 62581
    },
    {
      "FY": "FY11",
      "period": "2012/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヨーロッパ",
      "sales": 8002,
      "profit": 150,
      "assets": 6764
    },
    {
      "FY": "FY11",
      "period": "2012/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品製造販売事業",
      "sales": 39373,
      "profit": 10145,
      "assets": 36004
    },
    {
      "FY": "FY11",
      "period": "2012/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "その他事業",
      "sales": 16174,
      "profit": 627,
      "assets": 9955
    },
    {
      "FY": "FY12",
      "period": "2013/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 179601,
      "profit": 9547,
      "assets": 174137
    },
    {
      "FY": "FY12",
      "period": "2013/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "米州",
      "sales": 38822,
      "profit": 8667,
      "assets": 56246
    },
    {
      "FY": "FY12",
      "period": "2013/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "アジア・オセアニア",
      "sales": 41250,
      "profit": 9595,
      "assets": 82647
    },
    {
      "FY": "FY12",
      "period": "2013/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヨーロッパ",
      "sales": 7472,
      "profit": 281,
      "assets": 7936
    },
    {
      "FY": "FY12",
      "period": "2013/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品製造販売事業",
      "sales": 37072,
      "profit": 8982,
      "assets": 30323
    },
    {
      "FY": "FY12",
      "period": "2013/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "その他事業",
      "sales": 14973,
      "profit": 706,
      "assets": 9563
    },
    {
      "FY": "FY13",
      "period": "2014/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 180509,
      "profit": 9783,
      "assets": 180346
    },
    {
      "FY": "FY13",
      "period": "2014/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "米州",
      "sales": 49247,
      "profit": 11454,
      "assets": 75197
    },
    {
      "FY": "FY13",
      "period": "2014/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "アジア・オセアニア",
      "sales": 60986,
      "profit": 16753,
      "assets": 120536
    },
    {
      "FY": "FY13",
      "period": "2014/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヨーロッパ",
      "sales": 8632,
      "profit": -339,
      "assets": 9721
    },
    {
      "FY": "FY13",
      "period": "2014/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品製造販売事業",
      "sales": 35324,
      "profit": 8550,
      "assets": 38093
    },
    {
      "FY": "FY13",
      "period": "2014/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "その他事業",
      "sales": 15622,
      "profit": 1326,
      "assets": 12347
    },
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "アジア・オセアニア",
      "sales": 79176,
      "profit": 20396,
      "assets": 156195
    },
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヨーロッパ",
      "sales": 8891,
      "profit": -182,
      "assets": 9863
    },
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品製造販売事業",
      "sales": 32560,
      "profit": 5842,
      "assets": 37120
    },
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 177382,
      "profit": 11622,
      "assets": 180818
    },
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "米州",
      "sales": 54643,
      "profit": 12798,
      "assets": 84811
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "アジア・オセアニア",
      "sales": 97121,
      "profit": 26980,
      "assets": 164953
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヨーロッパ",
      "sales": 8621,
      "profit": 618,
      "assets": 9280
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品製造販売事業",
      "sales": 34813,
      "profit": 5361,
      "assets": 32379
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 179518,
      "profit": 9534,
      "assets": 183372
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "米州",
      "sales": 52736,
      "profit": 12778,
      "assets": 73271
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "アジア・オセアニア",
      "sales": 93364,
      "profit": 25307,
      "assets": 173745
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヨーロッパ",
      "sales": 7800,
      "profit": 491,
      "assets": 9030
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品製造販売事業",
      "sales": 27836,
      "profit": 2890,
      "assets": 26634
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 186532,
      "profit": 13813,
      "assets": 183500
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "米州",
      "sales": 45252,
      "profit": 10323,
      "assets": 69399
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "アジア・オセアニア",
      "sales": 109852,
      "profit": 30093,
      "assets": 200697
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヨーロッパ",
      "sales": 8342,
      "profit": 664,
      "assets": 10481
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品製造販売事業",
      "sales": 25661,
      "profit": 1322,
      "assets": 25203
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 189213,
      "profit": 17029,
      "assets": 181670
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "米州",
      "sales": 50158,
      "profit": 11279,
      "assets": 72971
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "アジア・オセアニア",
      "sales": 120784,
      "profit": 35156,
      "assets": 209586
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヨーロッパ",
      "sales": 8673,
      "profit": 518,
      "assets": 9663
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品製造販売事業",
      "sales": 21696,
      "profit": -1803,
      "assets": 17988
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 186879,
      "profit": 16431,
      "assets": 178691
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "米州",
      "sales": 48907,
      "profit": 11837,
      "assets": 75677
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "アジア・オセアニア",
      "sales": 122317,
      "profit": 31853,
      "assets": 229250
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヨーロッパ",
      "sales": 7940,
      "profit": 332,
      "assets": 9511
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品製造販売事業",
      "sales": 19670,
      "profit": -811,
      "assets": 14349
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 186682,
      "profit": 18209,
      "assets": 180889
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "米州",
      "sales": 48746,
      "profit": 12360,
      "assets": 86824
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "アジア・オセアニア",
      "sales": 114966,
      "profit": 26384,
      "assets": 237743
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヨーロッパ",
      "sales": 8564,
      "profit": 648,
      "assets": 10158
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品製造販売事業",
      "sales": 18123,
      "profit": 191,
      "assets": 12881
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 186518,
      "profit": 23767,
      "assets": 183235
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "米州",
      "sales": 41877,
      "profit": 10389,
      "assets": 74196
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "アジア・オセアニア",
      "sales": 128199,
      "profit": 24808,
      "assets": 272381
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヨーロッパ",
      "sales": 9413,
      "profit": 622,
      "assets": 10867
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品製造販売事業",
      "sales": 16992,
      "profit": 2634,
      "assets": 8497
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 195725,
      "profit": 28243,
      "assets": 190150
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "米州",
      "sales": 47388,
      "profit": 12554,
      "assets": 85857
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "アジア・オセアニア",
      "sales": 140465,
      "profit": 18711,
      "assets": 287756
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヨーロッパ",
      "sales": 9724,
      "profit": 116,
      "assets": 11374
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 231859,
      "profit": 47443,
      "assets": 216883
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "米州",
      "sales": 64920,
      "profit": 15974,
      "assets": 112125
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "アジア・オセアニア",
      "sales": 133274,
      "profit": 9760,
      "assets": 296973
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヨーロッパ",
      "sales": 10351,
      "profit": -311,
      "assets": 12239
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 243233,
      "profit": 49525,
      "assets": 227851
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "米州",
      "sales": 82186,
      "profit": 21683,
      "assets": 145224
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "アジア・オセアニア",
      "sales": 134803,
      "profit": 10794,
      "assets": 304569
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヨーロッパ",
      "sales": 12130,
      "profit": 143,
      "assets": 14081
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 233847,
      "profit": 37464,
      "assets": 240611
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "米州",
      "sales": 91822,
      "profit": 25769,
      "assets": 153677
    },
    {
      "FY": "FY25",
      "period": "2026/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "アジア・オセアニア",
      "sales": 136209,
      "profit": 12611,
      "assets": 297257
    },
    {
      "FY": "FY25",
      "period": "2026/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヨーロッパ",
      "sales": 12694,
      "profit": -91,
      "assets": 16407
    },
    {
      "FY": "FY25",
      "period": "2026/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 220386,
      "profit": 27668,
      "assets": 245813
    },
    {
      "FY": "FY25",
      "period": "2026/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "米州",
      "sales": 91120,
      "profit": 23798,
      "assets": 180888
    }
  ]
}